New support strategy for breast cancer
New assisted breast treatment plays a significant role in the treatment of breast cancer. It opens new avenues of treatment for many breast cancer patients and offers hope for more healing. Newly assisted chemotherapy is an important component of new assisted breast treatment. Chemotherapy before surgery is like a “pre-emptive strike” campaign on tumors. Its core advantage is that it can significantly reduce the size of the tumor. While the size of the tumour may be a luxury for many patients at the time of their diagnosis, new assisted chemotherapy, like the magic “mammoma magic”, reduces the size of the tumour, and gives breast-pupplanting possibilities to patients who could not otherwise be breast-protected, which is of extraordinary significance for the psychological and physical recovery of female patients. Furthermore, it can effectively reduce the risk of post-operative recurrence by striking at potential microcream cells that may have been transferred but not detected. In the case of partially late breast cancer, the new assisted chemotherapy can significantly increase the success rate of surgical sterilization by limiting the already difficult condition to a more favourable condition. Newly aided target-oriented treatment is an example of the excellence of precision care in breast cancer treatment, especially for Her2 positive breast cancer. This treatment uses drugs that are specific to cancer cell-specific targets to play a strong pre-operative anti-cancer role. Just as with precision-guided weapons, the target is the “prime” of the cancer cell, Her2 protein, and the cancer cell is invisible. This not only greatly inhibits the activity of tumour cells, but also improves the survival and post-operative quality of life of patients. More importantly, during the treatment, doctors can closely observe the tumour’s response to the target-to-drugs, like having a real-time “temporal monitor” to adjust the treatment programme in a timely and responsive manner to ensure that every step of the treatment works best. New assisted endocrine treatment is a mild and effective method for hormonal positive breast cancer patients. By regulating the hormonal levels in the body, it cleverly cut off the “nutrient supply” of cancer cell growth, thereby reducing the tumor. Newly assisted endocrinological treatment is undoubtedly a dawn for those who are old and infirm and unable to withstand the effects of surgery or chemotherapy, providing them with a viable path to treatment. However, there are challenges for new assisted breast treatment. Chemotherapy can lead to bone marrow inhibition, reduced physical resistance, and symptoms such as nausea and vomiting can seriously affect the quality of life of patients; the heart toxicity of target treatment also requires high vigilance. Therefore, throughout the treatment, doctors must closely monitor key indicators such as blood protocol, heart function and, if problems arise, take prompt measures to respond to ensure that new breast-aided treatment is of maximum benefit to the patient under safe conditions.
